| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/29/2006 | CA2591212A1 Use of a dihydroim1dazopyrazine derivative for treating or preventing pain |
| 06/28/2006 | EP1674574A1 Methods for Regulating Hematopoiesis using CpG-Oligonucleotides |
| 06/28/2006 | EP1674112A1 Compositions comprising an inhibitor of an acrab-like efflux pump for reducing microbial resistance to drugs |
| 06/28/2006 | EP1674108A2 Osteoporosis treatment |
| 06/28/2006 | EP1674099A1 Therapeutic combination of amlodipine and benazepril / benazeprilat |
| 06/28/2006 | EP1674084A2 Extended release oral dosage composition |
| 06/28/2006 | EP1674079A2 Pressurised metered dose inhalers (MDI) |
| 06/28/2006 | EP1674068A1 Dermal penetration enhancers and drug delivery systems involving same |
| 06/28/2006 | EP1673458A1 Poxvirus vector encoding retrovirus (eg hiv) and cytokine |
| 06/28/2006 | EP1673440A2 Multi-layered polymerizing hydrogels for tissue regeneration |
| 06/28/2006 | EP1673107A2 Pharmaceutical composition comprising a selective i1 imidazoline receptor agonist and an angiotensin ii receptor blocker |
| 06/28/2006 | EP1673102A1 Treatment and prevention of decubitus |
| 06/28/2006 | EP1673098A1 Methods and means for modulating lipid metabolism |
| 06/28/2006 | EP1673096A1 Use of a vitamin d3 analogue for the treatment of benign prostatic hyperplasia |
| 06/28/2006 | EP1673092A1 Heterocycle-substituted pteridine derivatives and their use in therapy |
| 06/28/2006 | EP1673076A1 Breast cancer treatment regimen |
| 06/28/2006 | EP1673062A2 Antimicrobial compositions and methods |
| 06/28/2006 | EP1558199A4 Therapeutic combination of carnitine and antioxidant polyphenols |
| 06/28/2006 | EP1440143B1 Device with recessed tracks for forming a cellular network |
| 06/28/2006 | EP1372636B1 Metronomic dosing of taxanes for inhibiting tumor growth |
| 06/28/2006 | EP1355644B1 The use of substituted azetidinone compounds for the treatment of sitosterolemia |
| 06/28/2006 | EP1268405B1 Treatment of tumors with rar alpha selective retinoid compounds in combination with other anti-tumor agents |
| 06/28/2006 | EP1267901B9 Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress |
| 06/28/2006 | EP1267861B1 Composition comprising paracetamol and niflumic acid |
| 06/28/2006 | EP1259243B1 Bupropion metabolites and methods of their synthesis and use |
| 06/28/2006 | EP1159756B1 Compounds for the treatment of cancer |
| 06/28/2006 | EP1156789B9 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 06/28/2006 | EP1061922B1 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
| 06/28/2006 | EP1060251B1 Phosphodiesterase 10 |
| 06/28/2006 | EP1011638A4 Small particle liposome aerosols for delivery of anti-cancer drugs |
| 06/28/2006 | CN1795011A A pharmaceutical composition comprising a p2x7-receptor antagonist and a tumour necrosis factor alpha |
| 06/28/2006 | CN1795002A Rock flour, especially dolomite-based medicament, for the treatment of cancer diseases |
| 06/28/2006 | CN1794994A Carbostyril derivatives and mood stabilizers for treating mood disorders |
| 06/28/2006 | CN1794991A Pharmaceutical composition containing histone deacetylase inhibitor |
| 06/28/2006 | CN1794983A Aqueous olanexidine solution, method of preparing the same, and disinfectant |
| 06/28/2006 | CN1794982A Use of compounds for the prevention of drug-induced cell toxicity |
| 06/28/2006 | CN1794981A Combination of an nmda receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders |
| 06/28/2006 | CN1794976A Dietary supplement and method for the treatment and prevention of digestive tract ulcers in equines and other animals |
| 06/28/2006 | CN1794974A 药物递送体系 Drug delivery system |
| 06/28/2006 | CN1261589C A beta-peptide screening method |
| 06/28/2006 | CN1261453C Platelet-derived growth factor D, DNA coding and uses thereof |
| 06/28/2006 | CN1261165C Preparation for prophylaxis of restenosis |
| 06/28/2006 | CN1261158C Application of growth hormone for preparation medicine with induced nerve protection function |
| 06/28/2006 | CN1261142C Use of a serra repens extract for the production of a medicament to treat prostate cancer |
| 06/28/2006 | CN1261098C p38-alpha kinase inhibitors |
| 06/28/2006 | CN1261095C Brain, spinal and nerve injure treatment |
| 06/28/2006 | CN1261094C New use of lipase inhibitors |
| 06/27/2006 | US7067649 Includes an endothelial specific enhancer element; especially modifications of the PPE promoter, which enhance its expression in response to hypoxia and angiogenesis. |
| 06/27/2006 | US7067639 Method to provide bacterial ghosts provided with antigens |
| 06/27/2006 | US7067629 Sodium channel in dorsal root ganglia |
| 06/27/2006 | US7067539 Cannabinoid receptor ligands |
| 06/27/2006 | US7067533 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 06/27/2006 | US7067519 human orexin receptor antagonists; analgesics, antidiabetic agents; sleep apnea, insomnia |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067506 Compounds useful for inhibiting Chk1 |
| 06/27/2006 | US7067503 17-aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase |
| 06/27/2006 | US7067502 A medicament containing formoterol or its pharmaceutically acceptable salt and/or mometasone furoate, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease |
| 06/27/2006 | US7067498 Feeding low viscosity fiber and starch hydrolyzates; antidiabetic agents |
| 06/27/2006 | US7067489 Hematopoietic stimulation |
| 06/27/2006 | US7067484 AL-1 neurotrophic factor treatments |
| 06/27/2006 | US7067474 A peptide or polypeptide obtained from the armadillo domain of human beta -catenin polypeptide which inhibits the interaction of human beta -catenin polypeptide and a transcription factor or tumor suppressor protein |
| 06/27/2006 | US7067296 Enzymatic polypeptide for use in the treatment of pain, inflammation, arthritis, cancer and alzheimer's disease |
| 06/27/2006 | US7067261 Methods and compositions for treatment of central nervous system disorders |
| 06/27/2006 | US7067248 Screening method for orthopoxvirus antivirals |
| 06/27/2006 | US7067158 Preparation for the relief of disease |
| 06/27/2006 | US7067144 Compositions and methods for systemic inhibition of cartilage degradation |
| 06/27/2006 | US7067139 Administering Product R, a peptide-nucleic acid preparation, to patients having rheumatoid arthritis; analgesics; antiinflammatory, -swelling, -arthritic agents |
| 06/27/2006 | US7067137 Method for treating post herpetic neuralgia by peripheral administration of a neurotoxin |
| 06/27/2006 | US7067126 Synthase enzymes having chemokine, angiogenic or angiostsatic activity, used for medical diagnosis and prognosis |
| 06/27/2006 | US7067119 Using polypeptides |
| 06/27/2006 | US7067117 Compounds and methods to inhibit or augment an inflammatory response |
| 06/27/2006 | US7067114 Delivery of antihistamines through an inhalation route |
| 06/27/2006 | US7067109 Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids |
| 06/22/2006 | WO2006066121A2 Combination of a glycine transporter (glyt1) inhibitor and an antipsychotic for the treatment of symptoms of schizophrenia as well as its preparation and use thereof |
| 06/22/2006 | WO2006065814A1 Compositions comprising pde4 modulators and their use for the treatment or prevention of airway inflammation |
| 06/22/2006 | WO2006065513A2 Oral treatment compositions containing an anti-adhesion agent, antibacterial agent and incompatible compound |
| 06/22/2006 | WO2006064861A1 Function inhibitor of adam10 or adam17 protein and method of screening the same |
| 06/22/2006 | WO2006064826A1 MEDICINAL COMPOSITION CONTAINING FBPase INHIBITOR |
| 06/22/2006 | WO2006064780A1 Therapeutic agent for constipation |
| 06/22/2006 | WO2006064757A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | WO2006064754A1 Preventive or therapeutic agent for sleep disorder |
| 06/22/2006 | WO2006064744A1 Medicinal composition for treating diabetes |
| 06/22/2006 | WO2006064686A1 Drug and method for preventing or relieving delayed nerve cell death |
| 06/22/2006 | WO2006064016A1 Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and hmg coa reductase inhibitors |
| 06/22/2006 | WO2006063707A2 Novel pharmaceutical composition containing at least one dolastatin 10 derivative |
| 06/22/2006 | WO2006063458A2 Inducing neurogenesis within a human brain |
| 06/22/2006 | WO2006063457A2 Improving cognitive function within a human brain |
| 06/22/2006 | WO2006044077A3 Controlled release composition with semi-permeable membrane and poloxamer flux enhancer |
| 06/22/2006 | WO2006024488A3 Medical stent provided with inhibitors of atp synthesis |
| 06/22/2006 | WO2005113005A3 Transcutaneous and/or transdermal transport of materials |
| 06/22/2006 | WO2005110481A3 Prolongation of survival of an allograft by inhibiting complement activity |
| 06/22/2006 | WO2005084671A3 Combination of voriconazole and an antifungal cyp2c19 inhibitor |
| 06/22/2006 | WO2005079851A3 Dopamine-agonist combination therapy with sedatives for improving sleep quality |
| 06/22/2006 | WO2004071419A3 Methods and compositions for modulating glutamate transport activity in the nervous system |
| 06/22/2006 | US20060136146 Modulators of ribosomal function and identification thereof |
| 06/22/2006 | US20060136136 Crystal structure of baff, and use thereof in drug design |
| 06/22/2006 | US20060135600 Brain-derived neurotrophic factor (BDNF) and antioxidant Neu 2000 which is 2-hydroxy-5-(2,3,5,6-tetrafluoro-4-trifluoromethylbenzylamino)benzoic acid; synergistic; neuroprotectant |
| 06/22/2006 | US20060135576 2-Amino-(imidazole, thiazole, or oxazole) derivatives; tyrosine kinase, endothelial growth factor, angiogenesis and fibroblast growth factor inhibitors; anticarcinogenic and antidiabetic agents |
| 06/22/2006 | US20060135568 Methods of treating microbial infections in humans and animals |
| 06/22/2006 | US20060135534 Pyrazine based inhibitors of glycogen synthase kinase 3 |